Table 1.

AML Patient Characteristics

CD34+
Specimen	Source	Status	karyotype	CD34%	FLT3/ITD	NPM	MUC1%*
AML1	BM	diagnosis	normal	95%	neg	neg	65%
AML2	BM	relapse	normal	20%	ND	ND	73%
AML3	BM	diagnosis	normal	32%	ND	ND	81%
AML4	BM	diagnosis	complex	90%	neg	neg	85%
AML5	BM	diagnosis	trisomy 8	79%	ND	ND	51%
AML6	PB	diagnosis	normal	99%	ND	ND	89%
AML7	PB	diagnosis	normal	99%	neg	neg	68%
AML8	BM	relapse	complex	17%	ND	ND	90%
AML9	BM	diagnosis	normal	70%	neg	neg	98%
AML10	PB	diagnosis	normal	10%	ND	ND	64%
AML11	BM	relapse	45,xx,inv (3)(q21q26.2),−7	57%	neg	neg	65%
AML12	BM	relapse	8;21 9q deletion	63%	neg	ND	44%
AML13	BM	diagnosis	trisomy 8 translocation:11; 17(q23;12–21) MLL	99%	ND	ND	90%
AML14	BM	diagnosis	normal	92%	neg	neg	57%
AML15	BM	diagnosis	normal	42%	pos	pos	47%
AML16	BM	diagnosis	complex	21%	neg	ND	56%
AML17	BM	diagnosis	complex	26%	ND	ND	97%
AML18	PB	diagnosis	2/20 trisomy 13(47 xy)	94%	ND	ND	32%
AML19	BM	diagnosis	normal	59%	pos	pos	92%
AML20	BM	diagnosis	trisomy 14	73%	neg	neg	36%
CD34−
Specimen	Source	Status	karyotype	CD34%	FLT3/ITD	NPM	MUC1%
AML21	BM	diagnosis	45,X,−Y[20]	0%	neg	pos	50%
AML22	BM	diagnosis	normal	2%	neg	pos	50%
AML23	PB	diagnosis	normal	0%	neg	pos	70%
AML24	BM	diagnosis	normal	1%	neg	pos	25%
AML25	BM	diagnosis	MLL	0.1%	neg	neg	52%
AML26	BM	diagnosis	normal	0.1%	pos	pos	92%

^*Results represent the percentage of CD34+ cells that are MUC1+.